Publication | Closed Access

Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial

Motor Neuron DiseaseNeurophysiologyNeurological DisorderNeuropathic PainRehabilitationNeuroscienceNeurologyCentral Nervous SystemSpasticity SymptomsNeurorehabilitationMedicineMotor DisorderSocial SciencesNeuropathology